COX-2 Inhibitor Reduces Serum PSA Levels Might Predict a Lower Risk of Prostatic Cancer in Men With LUTS/BPH With an Elevated PSA Level
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Celecoxib (Primary) ; Doxazosin (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 27 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Sep 2012 New trial record